generic

Pfizer and Mylan to Combine Off-Patent Drugs Businesses
M&A

Pfizer and Mylan to Combine Off-Patent Drugs Businesses

The combined company, which will sell Mylan’s EpiPen and Pfizer’s Viagra, could draw annual sales of more than $20 billion.
By Lauren Muskett | July 29, 2019
Read More